APT-1011 3 mg HS

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
98	好酸球性消化管疾患	1

98. 好酸球性消化管疾患

臨床試験数 : 172 / 薬物数 : 149 - (DrugBank : 39) / 標的遺伝子数 : 38 - 標的パスウェイ数 : 135

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05095116 (ClinicalTrials.gov)	February 10, 2022	14/10/2021	Expanded Access Protocol for Patients With Eosinophilic Esophagitis	APT-1011 (Fluticasone ODT) Expanded Access Protocol for Patients With Eosinophilic Esophagitis	Eosinophilic Esophagitis	Drug: APT-1011 3 mg HS	Ellodi Pharmaceuticals, LP	NULL	Available	12 Years	N/A	All			United States